Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2016.12.070
Abstract: Objective The Ministry of Health (MOH), Mongolia, is considering introducing 13-valent pneumococcal conjugate vaccine (PCV13) in its national immunization programme to prevent the burden of disease caused by Streptococcus pneumoniae. This study evaluates the cost-effectiveness… read more here.
Keywords: vaccination mongolia; cost effectiveness; valent pneumococcal; vaccination ... See more keywords